Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Melanoma × Tablets × Clear all

Phase

Status

Unknown 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Polycystic Ovary Syndrome 6 Neoplasms 5 Breast Neoplasms 4 Vomiting 2 Solid Tumors 2 Neoplasm Metastasis 2 Weight Gain 1 Venous Thromboembolism 1 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Urinary Bladder Neoplasms 1 Thrombocythemia, Essential 1 Stem Cell Transplant Complications 1 Skin Toxicity 1 Skin Neoplasms 1 Renal Insufficiency 1 Prostatic Neoplasms 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycythemia Vera 1 Parathyroid Neoplasms 1 Nausea 1 Myeloproliferative Disorders 1 Multiple Myeloma 1 Melanoma 1 Lung Neoplasms 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia, Hairy Cell 1 Leukemia, B-Cell 1

Interventions

Ipilimumab 96 pembrolizumab 80 aldesleukin 77 Nivolumab 75 Interleukin-2 46 Cyclophosphamide 46 Dacarbazine 44 trametinib 32 Vemurafenib 32 incomplete Freund's adjuvant 31 fludarabine phosphate 30 Temozolomide 30 sargramostim 28 dabrafenib 26 Bevacizumab 22 fludarabine 20 Paclitaxel 19 MART-1 Antigen 18 Cisplatin 18 montanide ISA 51 17 Interferon-alpha 17 Sorafenib 16 Carboplatin 16 Introns 15 Granulocyte-Macrophage Colony-Stimulating Factor 15 Filgrastim 14 tremelimumab 13 atezolizumab 13 Radiotherapy 13 Radiosurgery 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00083239 2007-06-08

Study of Talabostat in Advanced Melanoma

Point Therapeutics

Phase 2 Completed

Melanoma, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡